England moves to a single-dose HPV vaccine

by Cancer Research UKCredit: Cancer Research UKThe HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.

Updated on: February 01,2024

England moves to a single-dose HPV vaccine

by Cancer Research UKCredit: Cancer Research UKThe HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.

Updated on:February 01,2024

A solid vaccine for liquid tumors

byHarvard UniversityCredit: CC0 Public DomainAcute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherap

Updated on: December 20,2023

A solid vaccine for liquid tumors

byHarvard UniversityCredit: CC0 Public DomainAcute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherap

Updated on:December 20,2023

Scientists to improve cancer treatment effectiveness

byNational Research Nuclear UniversityCredit: CC0 Public DomainTogether with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the N

Updated on: December 18,2023

Scientists to improve cancer treatment effectiveness

byNational Research Nuclear UniversityCredit: CC0 Public DomainTogether with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the N

Updated on:December 18,2023

Long-term skin irritation linked to increased risk of tumor growth

by Kate Wighton,Imperial College LondonCredit: CC0 Public DomainAn antibody that usually helps defend the skin against harmful substances or infections may promote tumor growth during chronic ti

Updated on: December 20,2023

Long-term skin irritation linked to increased risk of tumor growth

by Kate Wighton,Imperial College LondonCredit: CC0 Public DomainAn antibody that usually helps defend the skin against harmful substances or infections may promote tumor growth during chronic ti

Updated on:December 20,2023

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on: December 20,2023

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on:December 20,2023

Rituximab Maintenance Effective for Autoimmune Cytopenias

August 2023Thomas R. CollinsPatients with autoimmune cytopenias had longer durations of response after induction treatment with rituximab when rituximab was continued as maintenance therapy compared w

Updated on: February 18,2024

Rituximab Maintenance Effective for Autoimmune Cytopenias

August 2023Thomas R. CollinsPatients with autoimmune cytopenias had longer durations of response after induction treatment with rituximab when rituximab was continued as maintenance therapy compared w

Updated on:February 18,2024

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a

Updated on: November 19,2023

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a

Updated on:November 19,2023

Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

by IOS PressSkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainThe drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duch

Updated on: May 26,2024

Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

by IOS PressSkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainThe drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duch

Updated on:May 26,2024

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on: March 30,2024

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on:March 30,2024

Patient-reported outcomes predict aromatase inhibitor adherence

by SWOGCredit: CC0 Public DomainIf you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients co

Updated on: December 22,2023

Patient-reported outcomes predict aromatase inhibitor adherence

by SWOGCredit: CC0 Public DomainIf you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients co

Updated on:December 22,2023

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c

Updated on: December 20,2023

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c

Updated on:December 20,2023

Financial toxicity after robotic prostate cancer surgery: Younger patients at higher risk

byWolters Kluwer HealthPatient-reported outcomes measures changes during follow-up for groups (a-d). EF indicates erectile function domain; FT, financial toxicity; ICIQ-SF, International Consult

Updated on: December 25,2023

Financial toxicity after robotic prostate cancer surgery: Younger patients at higher risk

byWolters Kluwer HealthPatient-reported outcomes measures changes during follow-up for groups (a-d). EF indicates erectile function domain; FT, financial toxicity; ICIQ-SF, International Consult

Updated on:December 25,2023